This poster presents Ncardia’s non-human primate (NHP) iPSC-derived ventricular cardiomyocyte platform, developed to help bridge in vivo NHP studies and human in vitro cardiac data and support translational interpretation of cardiac safety findings.
Download it now for a closer look at:
How NHP iPSC-derived cardiomyocytes can support the interpretation of species-related differences between preclinical in vivo studies and human in vitro findings
Whether you are investigating differences between preclinical and human findings or evaluating cardiac liabilities across species, this platform provides a scalable, reproducible NHP cardiomyocyte model for translational cardiac safety studies.